Supernus Pharmaceuticals, Inc.

SUPN | NASDAQ | 0 Followers
$32.03 -2.26% -$0.74
Follow
Overview Metrics Financials
Breakdown12/31/2024
USD
12/31/2023
USD
12/31/2022
USD
12/31/2021
USD
Total revenue661,817
+8.94%
607,521
-8.95%
667,238
+15.09%
579,775
-
Cost of revenue77,906
-7.01%
83,779
-3.95%
87,221
+16.20%
75,061
-
Gross profit583,911
+11.49%
523,742
-9.70%
580,017
+14.92%
504,714
-
Operating expense502,245
-5.06%
529,011
-1.01%
534,403
+25.68%
425,215
-
Operating income81,666
+1,649.93%
-5,269
-107.83%
67,303
-21.77%
86,029
-
Pretax Income97,870
+3,434.49%
2,769
-95.44%
60,743
-16.99%
73,175
-
Tax Provision24,005
+1,552.10%
1,453
+4,440.63%
32
-99.84%
19,751
-
Net income73,865
+5,512.84%
1,316
-97.83%
60,711
+13.64%
53,424
-
EPS1.34
+5,460.17%
0.02
-97.87%
1.13
+11.88%
1.01
-
Diluted EPS1.32
+5,469.62%
0.02
-97.72%
1.04
+6.12%
0.98
-
Average Shares55,100
+1.03%
54,536
+1.62%
53,665
+1.07%
53,099
-
Diluted Average Shares55,959
+0.81%
55,507
-10.01%
61,680
+13.47%
54,357
-
EBIT97,870
+1,787.92%
5,184
-92.36%
67,813
-29.80%
96,598
-
EBITDA178,284
+98.00%
90,043
-41.32%
153,443
+18.78%
129,187
-
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
visibility_off
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores
visibility_off

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
We use cookies to improve your experience on our site.
Menu StockBot
Tracker
Upgrade